Get the Stockscreener App
78.96
3.79%
2.88
Livanova Plc stock is traded at $78.96, with a volume of 341.62K.
It is up +3.79% in the last 24 hours and down -0.64% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$76.08
Open:
$76.9
24h Volume:
341.62K
Relative Volume:
0.59
Market Cap:
$4.35B
Revenue:
$1.43B
Net Income/Loss:
$107.13M
P/E Ratio:
40.76
EPS:
1.9372
Net Cash Flow:
$161.04M
1W Performance:
+4.02%
1M Performance:
-0.64%
6M Performance:
+21.22%
1Y Performance:
+47.53%
1-Day Range:
$76.19
$79.11
1-Week Range:
$75.13
$78.10
52-Week Range:
$48.82
$85.76
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
78.96 | 4.35B | 1.43B | 107.13M | 161.04M | 1.9372 |
ABT
Abbott Laboratories
|
104.80 | 181.34B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.48 | 122.13B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
292.16 | 112.06B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.09 | 63.90B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.14 | 50.80B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-26 | Initiated | Barclays | Overweight |
| Dec-19-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-01-25 | Downgrade | Goldman | Buy → Neutral |
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Chief legal officer at LivaNova (LIVN) awarded 6,291 stock units vesting through 2029 - Stock Titan
Understanding Momentum Shifts in (LIVN) - Stock Traders Daily
LivaNova Director Sells 1,650 Shares for $131,500 - The Motley Fool
LivaNova (NASDAQ: LIVN) officer plans 3,500-share sale from 2026 stock award vesting - Stock Titan
Director at LivaNova (LIVN) sells 3,500 shares in open-market trade - Stock Titan
LivaNova (LIVN) Falls 1.64% to $79.38, Hovering at the Middle of Its Trading RangeSwing Entry Signals - siam.in
LivaNova PLC (NASDAQ:LIVN) Combines Strong Growth With a Timely Technical Setup - ChartMill
Director at LivaNova (NASDAQ: LIVN) sells 2,300 shares - Stock Titan
LivaNova (NASDAQ:LIVN) Combines Growth and Reasonable Valuation - ChartMill
LivaNova (NASDAQ: LIVN) executive plans stock sale - Stock Titan
LivaNova (LIVN) Declines 1.5% to $81.13 Amid Medical Device Sector CautionDiagonal Spread Trade - vinanet.vn
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova (LIVN) Director Francesco Bianchi Sells 1,650 Shares - GuruFocus
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September - finance.yahoo.com
LivaNova stock gains as Piper Sandler raises price target on strong Q2 results - ad-hoc-news.de
LivaNova (NASDAQ: LIVN) officer lines up six-figure stock sale - Stock Titan
LivaNova PLC (LIVN) director sells 1,650 shares - Stock Titan
LIVN Reiterated by Piper Sandler -- Price Target Raised to $90 - GuruFocus
Piper Sandler raises Livanova stock price target on cardiopulmonary growth outlook - Investing.com
LivaNova stock holds near 80 USD as investors digest latest earnings and ownership shift - ad-hoc-news.de
(LIVN) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
LivaNova (NASDAQ: LIVN) officer to sell 1,650 shares - Stock Titan
LivaNova: Quantitative Stock of the Week - Barron's
Is LivaNova (LIVN) Fairly Valued As Growth Hopes Meet Reimbursement Risks? - sahmcapital.com
LivaNova: Careful About The Valuation And Upside (NASDAQ:LIVN) - Seeking Alpha
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move - vinanet.vn
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move - dars.gov.et
LivaNova (LIVN) Results Check: Profit Per Share Surpasses Its Benchmark in Latest Trading; Closing Move: Shares Finish 0.61% Down in the Available RecordRevenue Growth Report - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionOne-Time Gain Impact - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionEarnings Manipulation Risk - vinanet.vn
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionSegment Revenue Breakdown - dars.gov.et
LivaNova (LIVN) Earnings Snapshot: EPS Prints Above Forecast; Share Response: The Market Price Advances 0.68% in the Latest SessionBook Value Growth - dars.gov.et
LIVN Looks 23.4% Overvalued on GF Value™ - GuruFocus
LivaNova (NASDAQ:LIVN) Downgraded by Zacks Research to "Hold" - MarketBeat
LivaNova PLC (LIVN) Stock Down 3.3% but Still Overvalued -- GF S - GuruFocus
Anne Liddy Joins LivaNova as Chief Legal Officer - Medical Product Outsourcing
LivaNova (NASDAQ:LIVN) Gains Attention After Strong Results - Kalkine Media
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseCall Wall - dars.gov.et
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseDip Buy Trade - vinanet.vn
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordAnalyst Consensus Shift - dars.gov.et
LivaNova (LIVN) Reported Quarter: Profit Per Share Surpasses Its Benchmark at the Close; Share-Price Check: Shares Move 1.57% Lower in the Available RecordNegative Surprise Momentum - Vinanet
LivaNova (NASDAQ:LIVN) Combines Strong Growth With a Promising Technical Breakout Setup - ChartMill
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseVolatility Skew - siam.in
LivaNova (LIVN) End-of-Day Review: Ends Down by 1.99% at $79.86 for the Current Session; Trading Range: the Price Remains Bounded by the Supplied Support and Resistance at the CloseBuyback Factor - dars.gov.et
LivaNova PLC $LIVN Stake Lessened by Bank of America Corp DE - MarketBeat
Ahmet Tezel Executes Sell Order: Offloads $876K In LivaNova Stock - Benzinga
LivaNova CIO Ahmet Tezel Reports Stock Transactions and Ownership Update - Kalkine Media
LivaNova PLC (LIVN) Stock forecasts - Yahoo Finance UK
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Officer |
Sep 10 '26 |
Proposed Sale |
78.01 |
3,500 |
273,032 |
0 |
| Story Brooke | Director |
Sep 04 '26 |
Sale |
81.42 |
2,300 |
187,270 |
7,488 |
| Story Brooke | Officer |
Sep 04 '26 |
Proposed Sale |
81.42 |
2,300 |
187,270 |
0 |
| Poletti Franco | Officer |
Sep 02 '26 |
Proposed Sale |
82.09 |
10,755 |
882,888 |
0 |
| Bianchi Francesco | Director |
Aug 31 '26 |
Sale |
79.72 |
1,650 |
131,538 |
7,934 |
| Bianchi Francesco | Officer |
Aug 31 '26 |
Proposed Sale |
79.72 |
1,650 |
131,538 |
0 |
| Tezel Ahmet | Officer |
Aug 11 '26 |
Proposed Sale |
78.48 |
2,675 |
209,942 |
0 |
| Tezel Ahmet | Chief Innovation Officer |
Aug 11 '26 |
Sale |
77.74 |
2,675 |
207,942 |
6,090 |
| Tezel Ahmet | Chief Innovation Officer |
Aug 11 '26 |
Option Exercise |
52.68 |
12,692 |
668,615 |
18,782 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):